MAOA is associated with methylphenidate improvement of oppositional symptoms in boys with attention deficit hyperactivity disorder

dc.contributor.author	Guimarães, Ana Paula Miranda	pt_BR
dc.contributor.author	Zeni, Cristian Patrick	pt_BR
dc.contributor.author	Polanczyk, Guilherme Vanoni	pt_BR
dc.contributor.author	Genro, Júlia Pasqualini	pt_BR
dc.contributor.author	Roman, Tatiana	pt_BR
dc.contributor.author	Rohde, Luis Augusto Paim	pt_BR
dc.contributor.author	Hutz, Mara Helena	pt_BR
dc.date.accessioned	2016-09-27T02:14:18Z	pt_BR
dc.date.issued	2009	pt_BR
dc.identifier.issn	1461-1457	pt_BR
dc.identifier.uri	http://hdl.handle.net/10183/148505	pt_BR
dc.format.mimetype	application/pdf	pt_BR
dc.language.iso	eng	pt_BR
dc.relation.ispartof	International journal of neuropsychopharmacology. Cambridge. Vol. 12, no. 5 (Jun. 2009), p. 709-714	pt_BR
dc.rights	Open Access	en
dc.subject	ADHD	en
dc.subject	Transtorno do déficit de atenção com hiperatividade	pt_BR
dc.subject	Monoaminoxidase	pt_BR
dc.subject	MAOA	en
dc.subject	Methylphenidate	en
dc.subject	Metilfenidato	pt_BR
dc.subject	Farmacogenética	pt_BR
dc.subject	Oppositional symptoms	en
dc.subject	Diagnóstico	pt_BR
dc.subject	Pharmacogenetic	en
dc.title	MAOA is associated with methylphenidate improvement of oppositional symptoms in boys with attention deficit hyperactivity disorder	pt_BR
dc.type	Artigo de periódico	pt_BR
dc.identifier.nrb	000708852	pt_BR
dc.type.origin	Estrangeiro	pt_BR

Este ítem está licenciado en la Creative Commons License